60 Degrees Pharmaceutical... (SXTP)
0.91
0.01 (1.00%)
At close: Jan 15, 2025, 3:59 PM
0.95
4.97%
After-hours Jan 15, 2025, 04:02 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 |
| PE Ratio | -12.87 | -52.53 | -76.37 | -107.03 |
| PS Ratio | 191.16 | 1.45K | 279.84 | 148.85 |
| PB Ratio | 9.95 | -13.77 | -18.47 | -18.55 |
| P/FCF Ratio | -10.4 | -303.43 | -474.37 | -1.36K |
| P/OCF Ratio | -10.67 | -321.5 | -500.23 | -1.94K |
| OCF/S Ratio | -17.92 | -4.52 | -0.56 | -0.08 |
| Debt / Equity Ratio | 0.04 | -0.95 | -1.07 | -0.91 |
| Quick Ratio | 2.39 | 0.02 | 0.77 | 0.98 |
| Current Ratio | 2.55 | 0.05 | 1.85 | 1.70 |
| Asset Turnover | 0.03 | 0.17 | 0.83 | 0.84 |
| Interest Coverage | -2.25 | -0.44 | -0.35 | -0.16 |
| Return on Equity (ROE) | -0.77 | 0.26 | 0.24 | 0.17 |
| Return on Assets (ROA) | -0.48 | -4.77 | -3.05 | -1.16 |
| Return on Capital (ROIC) | -1.04 | 0.08 | -1.48 | -0.36 |
| Dividend Yield | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -87.15% | -93.71% | 26.68% | 67.77% |
| Net Profit Margin | -1.49K% | -2.77K% | -366.42% | -139.08% |
| Pretax Profit Margin | -1.50K% | -2.77K% | -367.07% | -139.71% |
| Operating Profit Margin | -2.03K% | -784.22% | -96.88% | -19.17% |
| FCF Margin | -1.84K% | -479.42% | -58.99% | -10.92% |
| EBITDA Margin | -562.58% | -944.92% | -87.46% | -15.64% |